Characterization of a novel acidic phospholipase A 2 isolated from the venom of Bothrops mattogrossensis: From purification to structural modeling.
Autor: | de Melo Cordeiro Eulálio M; Laboratory of Cellular Immunology Applied to Health, Oswaldo Cruz Foundation, FIOCRUZ Rondônia, Porto Velho, RO, Brazil; Laboratory of Protein Biotechnology and Bioactive Compounds (LABIOPROT), Oswaldo Cruz Foundation, FIOCRUZ Rondônia, Porto Velho, RO, Brazil., de Lima AM; Laboratory of Protein Biotechnology and Bioactive Compounds (LABIOPROT), Oswaldo Cruz Foundation, FIOCRUZ Rondônia, Porto Velho, RO, Brazil., Brant RSC; Carlos Chagas Institute (ICC), Mass Spectrometry Facility of FIOCRUZ Paraná, Curitiba, PR, Brazil., Francisco AF; Laboratory of Protein Biotechnology and Bioactive Compounds (LABIOPROT), Oswaldo Cruz Foundation, FIOCRUZ Rondônia, Porto Velho, RO, Brazil., Santana HM; Laboratory of Cellular Immunology Applied to Health, Oswaldo Cruz Foundation, FIOCRUZ Rondônia, Porto Velho, RO, Brazil., Paloschi MV; Laboratory of Cellular Immunology Applied to Health, Oswaldo Cruz Foundation, FIOCRUZ Rondônia, Porto Velho, RO, Brazil., da Silva Setúbal S; Laboratory of Cellular Immunology Applied to Health, Oswaldo Cruz Foundation, FIOCRUZ Rondônia, Porto Velho, RO, Brazil., da Silva CP; Laboratory of Cellular Immunology Applied to Health, Oswaldo Cruz Foundation, FIOCRUZ Rondônia, Porto Velho, RO, Brazil., Silva MDS; Laboratory of Cellular Immunology Applied to Health, Oswaldo Cruz Foundation, FIOCRUZ Rondônia, Porto Velho, RO, Brazil., Boeno CN; Laboratory of Cellular Immunology Applied to Health, Oswaldo Cruz Foundation, FIOCRUZ Rondônia, Porto Velho, RO, Brazil., Kayano AM; Laboratory of Protein Biotechnology and Bioactive Compounds (LABIOPROT), Oswaldo Cruz Foundation, FIOCRUZ Rondônia, Porto Velho, RO, Brazil; Center for Research in Tropical Medicine (CEPEM/SESAU-RO), Porto Velho, RO, Brazil., Rita PHS; Bioterium of Dom Bosco Catholic University (UCDB), Campo Grande, MS, Brazil., de Azevedo Calderon L; Center for the Study of Biomolecules Applied to Health (CEBio), Oswaldo Cruz Foundation, Fiocruz Rondônia, Porto Velho, RO, Brazil., Soares AM; Laboratory of Protein Biotechnology and Bioactive Compounds (LABIOPROT), Oswaldo Cruz Foundation, FIOCRUZ Rondônia, Porto Velho, RO, Brazil; National Institute of Science and Technology of Epidemiology of Western Amazon, INCT-EpiAmO, Brazil., Salvador DPM; Toxic Protein Crystallography Laboratory (CPrTox-Lab), Federal University of Paraíba (UFPB), João Pessoa, PB, Brazil., Zuliani JP; Laboratory of Cellular Immunology Applied to Health, Oswaldo Cruz Foundation, FIOCRUZ Rondônia, Porto Velho, RO, Brazil; Department of Medicine, Federal University of Rondonia (UNIR), Porto Velho, RO, Brazil. Electronic address: juliana.zuliani@fiocruz.br. |
---|---|
Jazyk: | angličtina |
Zdroj: | International journal of biological macromolecules [Int J Biol Macromol] 2024 Dec 26; Vol. 292, pp. 139217. Date of Electronic Publication: 2024 Dec 26. |
DOI: | 10.1016/j.ijbiomac.2024.139217 |
Abstrakt: | Phospholipases A Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. (Copyright © 2024 Elsevier B.V. All rights reserved.) |
Databáze: | MEDLINE |
Externí odkaz: |